BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2025 8:47:58 AM | Browse: 340 | Download: 889
Publication Name World Journal of Hepatology
Manuscript ID 103409
Country China
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention
Manuscript Source Unsolicited Manuscript
All Author List Lei-Yang Jin, Kai Wang and Bo-Tao Xu
ORCID
Author(s) ORCID Number
Lei-Yang Jin http://orcid.org/0009-0007-5321-4343
Kai Wang http://orcid.org/0009-0000-9230-4383
Bo-Tao Xu http://orcid.org/0000-0002-4275-0489
Funding Agency and Grant Number
Corresponding Author Lei-Yang Jin, Assistant Professor, MD, Department of Hepatobiliary Surgery, Zhuji People’s Hospital, No. 9 Jianmin Road, Taozhu Street, Zhuji 311800, Zhejiang Province, China. 15968561792@163.com
Key Words Body mass index; Dietary intervention; Fatty liver; Genetic factors; Liver health; Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus
Core Tip The high prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in newly diagnosed type 2 diabetes mellitus (T2DM) patients emphasizes the importance of regular liver health assessments in diabetes care. Screening should include liver function tests and ultrasound imaging for early detection. Dietary changes, such as reducing saturated fat, along with lifestyle interventions, can improve liver health. Educating patients on monitoring body mass index and waist circumference promotes proactive health management. A region-specific MASLD risk model could enhance screening accuracy, while further research into genetic and environmental factors may reveal the disease’s mechanisms and guide prevention strategies.
Publish Date 2025-01-06 08:47
Citation

Jin LY, Wang K, Xu BT. High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention. World J Hepatol 2025; 17(1): 103409

URL https://www.wjgnet.com/1948-5182/full/v17/i1/103409.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i1.103409
Full Article (PDF) WJH-17-103409-with-cover.pdf